دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Editorial Board
doi : 10.1016/S0085-2538(23)00836-0
Volume 105, Issue 1, Supplement, January 2024, Page A1
Subscription Information
doi : 10.1016/S0085-2538(23)00837-2
Volume 105, Issue 1, Supplement, January 2024, Page A2
Title Page
doi : 10.1016/S0085-2538(23)00838-4
Volume 105, Issue 1, Supplement, January 2024, Page A3
Table of Contents
doi : 10.1016/S0085-2538(23)00839-6
Volume 105, Issue 1, Supplement, January 2024, Page A4
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
doi : 10.1016/j.kint.2023.09.002
Volume 105, Issue 1, Supplement, January 2024, Pages S1-S69
The structure of megalin: shedding new light on receptor-mediated endocytosis
Svenja Keller 1 , Alessandro Luciani 1 and Olivier Devuyst 1,2
doi : 10.1016/j.kint.2023.05.026
Volume 105, Issue 1, January 2024, Pages 11-14
Multipopulation genome-wide association meta-analysis in pediatric steroid-sensitive nephrotic syndrome
Olivia Boyer 1 and Guillaume Dorval
doi : 10.1016/j.kint.2023.08.022
Volume 105, Issue 1, January 2024, Pages 14-17
YB-1: the Jekyll and Hyde of kidney disease?
Phillip Kantharidis 1 and Mark E. Cooper
doi : 10.1016/j.kint.2023.10.020
Volume 105, Issue 1, January 2024, Pages 18-20
The T-cell environment: may the regulatory force be with you
Xunrong Luo 1,2 and Stuart Knechtle
doi : 10.1016/j.kint.2023.10.023
Volume 105, Issue 1, January 2024, Pages 20-22
Regulators of necroinflammation in acute kidney injury
Hans-Joachim Anders 1 , Joachim Andrassy 2 and Julia Lichtnekert
doi : 10.1016/j.kint.2023.10.019
Volume 105, Issue 1, January 2024, Pages 22-25
Leveraging multimodal chromatin profiling to identify a new potential driver of diabetic kidney disease
Yoshiharu Muto 1 and Benjamin D. Humphreys
doi : 10.1016/j.kint.2023.10.021
Volume 105, Issue 1, January 2024, Pages 25-27
A new alternative: inhibiting complement activation in patients with IgA nephropathy
Ju¨ rgen Floege
doi : 10.1016/j.kint.2023.10.012
Volume 105, Issue 1, January 2024, Pages 28-30
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis
Brad H. Rovin 1 , Isabelle M. Ayoub 1 , Tak Mao Chan 2 , Zhi-Hong Liu 3 , Juan M. Mej?´a-Vilet 4 , Ethan M. Balk 5 , Craig E. Gordon 6 , Gaelen Adam 5 , Marcello A. Tonelli 7 , Michael Cheung 8 , Amy Earley 8 and Ju¨ rgen Floege
doi : 10.1016/j.kint.2023.09.001
Volume 105, Issue 1, January 2024, Pages 31-34
Conservative kidney management and kidney supportive care: core components of integrated care for people with kidney failure
Sara N. Davison 1 , Wolfgang Pommer 2,3 , Mark A. Brown 4,5 , Claire A. Douglas 6 , Samantha L. Gelfand 7,8,9 , Irmingarda P. Gueco 10 , Barnaby D. Hole 11 , Sumiko Homma 12 , Ru¨ meyza T. Kazanc?oglu 13 , Harumi Kitamura 14 , Sahar H. Koubar 15 , Rene Krause 16 , Kelly C. Li 4,5 , Aoife C. Lowney 17,18,19 , Shankar P. Nagaraju 20 , Abdou Niang 21 , Gregorio T. Obrador 22 , Yoichi Ohtake 23 , Jane O. Schell 24 , Jennifer S. Scherer 25 , Brendan Smyth4,5,26 , Kaichiro Tamba 27 , Nandini Vallath 28 , Nicola Wearne 29 , Elena Zakharova 30 , Carlos Zu´ n? iga, SM 31 and Frank P. Brennan
doi : 10.1016/j.kint.2023.10.001
Volume 105, Issue 1, January 2024, Pages 35-45
An introduction to realist evaluation and synthesis for kidney research
Dominic M. Taylor 1 , Ailish M.S. Nimmo 2,3 , Barnaby Hole 1,4 and G.J. Melendez-Torres
doi : 10.1016/j.kint.2023.09.015
Volume 105, Issue 1, January 2024, Pages 46-53
Exploiting the neonatal crystallizable fragment receptor to treat kidney disease
James F. Dylewski 1,2 , George Haddad 1 and Judith Blaine
doi : 10.1016/j.kint.2023.09.024
Volume 105, Issue 1, January 2024, Pages 54-64
Glomerular-tubular crosstalk via cold shock Y-box binding protein-1 in the kidney
Rajiv Rana 1 , Jayakumar Manoharan1 , Ahmed Elwakiel 1 , Silke Zimmermann 1 , Jonathan A. Lindquist 2 , Dheerendra Gupta 1 , Moh’d Mohanad Al-Dabet 1,3 , Ihsan Gadi 1 , Jo¨ rg Fallmann 4 , Kunal Singh 1 , Anubhuti Gupta1 , Ronald Biemann 1 , Sabine Brandt 2 , Bekas Alo 5 , Paul Kluge 5 , Ravindra Garde 5 , Christina Lamers 5 , Khurrum Shahzad 1 , Georg Ku¨ nze 5,6 , Shrey Kohli 1 , Peter R. Mertens 2,7 and Berend Isermann
doi : 10.1016/j.kint.2023.09.014
Volume 105, Issue 1, January 2024, Pages 65-83
Multiple infusions of ex vivo-expanded regulatory T cells promote CD163+ myeloid cells and kidney allograft survival in non-lymphodepleted non-human primates
Kazuki Sasaki 1 , Masahiko Kubo 1 , Yu-chao Wang 1 , Lien Lu 1 , Veronica Vujevich 1 , Michelle A. Wood-Trageser 2 , Kayla Golnoski 2 , Andrew Lesniak 2 , Vikraman Gunabushanam 1 , Armando Ganoza 1 , Martin J. Wijkstrom 1 , Abhinav Humar 1 , Anthony J. Demetris 2 , Angus W. Thomson 1,3 and Mohamed B. Ezzelarab
doi : 10.1016/j.kint.2023.09.021
Volume 105, Issue 1, January 2024, Pages 84-98
IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury
Kensei Taguchi 1,5 , Sho Sugahara 1,5 , Bertha C. Elias 1 , Navjot S. Pabla 2 , Guillaume Canaud 3 and Craig R. Brooks
doi : 10.1016/j.kint.2023.09.020
Volume 105, Issue 1, January 2024, Pages 99-114
The transcription factor GATA6 accelerates vascular smooth muscle cell senescence-related arterial calcification by counteracting the role of anti-aging factor SIRT6 and impeding DNA damage repair
Xiaoxue Li 1,2 , Aiting Liu 1,2 , Chen Xie 2 , Yanlian Chen 2 , Kuan Zeng 3 , Changming Xie 1,2 , Zhengzhipeng Zhang 1,2 , Pei Luo 4 and Hui Huang
doi : 10.1016/j.kint.2023.09.028
Volume 105, Issue 1, January 2024, Pages 115-131
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation
Karly C. Sourris 1,2,14 , Yi Ding 2,3,14 , Scott S. Maxwell 4 , Annas Al-sharea 5 , Phillip Kantharidis 1 , Muthukumar Mohan 1 , Carlos J. Rosado 1 , Sally A. Penfold 2 , Claus Haase 3 , Yangsong Xu 5 , Josephine M. Forbes 6 , Simon Crawford 7 , Georg Ramm 7 , Brooke E. Harcourt 8 , Karin Jandeleit-Dahm 1 , Andrew Advani 9 , Andrew J. Murphy 5 , Daniel B. Timmermann 10 , Anil Karihaloo 11 , Lotte Bjerre Knudsen 10 , Assam El-Osta 4 , Daniel J. Drucker 12 , Mark E. Cooper 1,15 and Melinda T. Coughlan 1,2,13
doi : 10.1016/j.kint.2023.09.029
Volume 105, Issue 1, January 2024, Pages 132-149
Chromatin accessibility analysis and architectural profiling of human kidneys reveal key cell types and a regulator of diabetic kidney disease
Minho Eun1,7 , Donggun Kim 1,7 , So-I Shin1 , Hyun Oh Yang 2 , Kyoung-Dong Kim 2 , Sin Young Choi 1 , Sehoon Park 3 , Dong Ki Kim 3,4 , Chang Wook Jeong 5 , Kyung Chul Moon 6 , Hajeong Lee 3,4 and Jihwan Park
doi : 10.1016/j.kint.2023.09.030
Volume 105, Issue 1, January 2024, Pages 150-164
Development of an automated estimation of foot process width using deep learning in kidney biopsies from patients with Fabry, minimal change, and diabetic kidney diseases
David Smerkous 1,2 , Michael Mauer 3,4 , Camilla T?ndel 5,6 , Einar Svarstad 7 , Marie-Claire Gubler 8 , Robert G. Nelson 9 , Joa?o-Paulo Oliveira 10 , Forough Sargolzaeiaval 1 and Behzad Najafian
doi : 10.1016/j.kint.2023.09.011
Volume 105, Issue 1, January 2024, Pages 165-176
Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis
Laura Lucientes-Continente1,2,11 , Gema Ferna´ndez-Jua´rez 3,11 , Ba´rbara Ma´rquez-Tirado 1,2 , Laura Jime´nez-Villegas 1,2 , Mercedes Acevedo 4 , Teresa Cavero 5 , Lu?´s Sa´nchez Ca´mara 6 , Juliana Draibe 7,8 , Paula Anton-Pampols 7,8 , Fernando Caravaca-Fonta´n 5 , Manuel Praga 5,9 , Javier Villacorta 10 and Elena Goicoechea de Jorge
doi : 10.1016/j.kint.2023.10.013
Volume 105, Issue 1, January 2024, Pages 177-188
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
Hong Zhang 1 , Dana V. Rizk 2 , Vlado Perkovic 3 , Bart Maes 4 , Naoki Kashihara 5 , Brad Rovin 6 , Herna´n Trimarchi 7 , Ben Sprangers 8,9 , Matthias Meier 10 , Dmitrij Kollins 10 , Olympia Papachristofi 10 , Julie Milojevic 11 , Guido Junge 11 , Prasanna Kumar Nidamarthy 12 , Alan Charney 13 and Jonathan Barratt
doi : 10.1016/j.kint.2023.09.027
Volume 105, Issue 1, January 2024, Pages 189-199
Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease
Sunil Bhandari 1 , Samir Mehta 2 , Arif Khawaja 3 , John G.F. Cleland 4 , Natalie Ives 2 and Paul Cockwell
doi : 10.1016/j.kint.2023.09.012
Volume 105, Issue 1, January 2024, Pages 200-208
Asymptomatic migration of a peritoneal dialysis catheter
James Larkworthy 1 , Farid Ghalli 1,2 and Chloe Mortensen
doi : 10.1016/j.kint.2023.07.029
Volume 105, Issue 1, January 2024, Page 209
Kidney allograft venous obstruction from polycystic kidney disease
David Massicotte-Azarniouch 1 , Pierre-Antoine Brown 1 , Jana Pichovsky 2 and Jeffrey E. Warren 3
doi : 10.1016/j.kint.2023.07.028
Volume 105, Issue 1, January 2024, Page 210
The Case | Refractory anemia in a patient undergoing dialysis
Kati Kaartinen 1 , P?ivi Schenk2 , Anne R?is?nen-Sokolowski 3 , Johannes Dunkel 3 , Anu Marttila 2 , Mika Huuskonen 2 and Ville Varmavuo 2
doi : 10.1016/j.kint.2023.08.017
Volume 105, Issue 1, January 2024, Pages 211-212
Corrigendum to “A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants.� Kidney Int. 2023;103:962–972
Georgia Malakasioti 1 , Daniela Iancu 2 , Anastasiia Milovanova 3 , Alexey Tsygin 3 , Tomoko Horinouchi 4 , China Nagano 4 , Kandai Nozu 4 , Koichi Kamei 5 , Shuichiro Fujinaga 6 , Kazumoto Iijima 7 , Hee Gyung Kang 8 , Rajiv Sinha 9 , Biswanath Basu 10 , William Morello 11 , Giovanni Montini 11,12 , Aoife Waters 13 , Olivia Boyer 14 , Zeynep Yu¨ ru¨ k Y?ld?r?m 15 , Sibel Yel 16 , _Ismail Dursun 16 , Hugh J. McCarthy17 , Marina Vivarelli 18 , Larisa Prikhodina 19 , Martine T.P. Besouw 20 , Eugene Yu-hin Chan 21 , Wenyan Huang22 , Markus J. Kemper 23 , Sebastian Loos 23 , Chanel Prestidge 24 , William Wong 24 , Galia Zlatanova 25 , Rasmus Ehren 26 , Lutz T. Weber 26 , Hassib Chehade 27 , Nakysa Hooman 28 , Marcin Tkaczyk 29 , Ma?gorzata Stanczyk 29 , Michael Miligkos 30 and Kjell Tullus 13 ; on behalf of the CNI in Monogenic SRNS Study Investigators
doi : 10.1016/j.kint.2023.10.006
Volume 105, Issue 1, January 2024, Pages 213-214
Corrigendum to “A novel nanoluciferase transgenic reporter measures proteinuria in zebrafish.� Kidney Int. 2022;102:815–827
Richard W. Naylor1 , Emmanuel Lemarie2 , Anthony Jackson-Crawford 3 , J. Bernard Davenport 1 , Aleksandr Mironov 4 , Martin Lowe 2 and Rachel Lennon
doi : 10.1016/j.kint.2023.11.001
Volume 105, Issue 1, January 2024, Pages 214-215
Subscription Information
doi : 10.1016/S0085-2538(23)00805-0
Volume 105, Issue 1, January 2024, Page A2
Table of Contents
doi : 10.1016/S0085-2538(23)00806-2
Volume 105, Issue 1, January 2024, Pages A3-A6
